FDA Inspection
Taro Pharmaceuticals Inc.Taro Pharmaceuticals Inc. – FDA Inspection, Jul 29, 2016
Record Details
This FDA Inspection record concerns Taro Pharmaceuticals Inc., with an inspection on July 29, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Taro Pharmaceuticals Inc.
- Inspection Date
- July 29, 2016
- Product Type
- Drugs
View Company Profile
ID · 48a32949-7f77-49a7-b273-e98b9542286a
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 984831
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Taro Pharmaceuticals Inc.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| March 27, 2026 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 20, 2024 | Not classified | Office of Inspections and Investigations | |
| September 16, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 3, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 20, 2017 | VAI | Office of Inspections and Investigations | Generic Drug Evaluation |
Other documents for Taro Pharmaceuticals Inc.
- FDA Inspection 1312804 - 2026-03-27
- FDA Inspection 1257703 - 2024-09-20
- FDA Inspection 1180887 - 2022-09-16
- FDA Inspection 1088553 - 2019-05-03
- FDA Inspection 1001628 - 2017-01-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.